Literature DB >> 27998209

Immunodepletion and Hypoxia Preconditioning of Mouse Compact Bone Cells as a Novel Protocol to Isolate Highly Immunosuppressive Mesenchymal Stem Cells.

Kisha Nandini Sivanathan1,2, Stan Gronthos3,4, Shane T Grey5, Darling Rojas-Canales1,2, Patrick T Coates1,2,6.   

Abstract

Compact bones (CB) are major reservoirs of mouse mesenchymal stem cells (mMSC). Here, we established a protocol to isolate MSC from CB and tested their immunosuppressive potential. Collagenase type II digestion of BM-flushed CB from C57B/6 mice was performed to liberate mMSC precursors from bone surfaces to establish nondepleted mMSC. CB cells were also immunodepleted based on the expression of CD45 (leukocytes) and TER119 (erythroid cells) to eliminate hematopoietic cells. CD45-TER119- CB cells were subsequently used to generate depleted mMSC. CB nondepleted and depleted mMSC progenitors were cultured under hypoxic conditions to establish primary mMSC cultures. CB depleted mMSC compared to nondepleted mMSC showed greater cell numbers at subculturing and had increased functional ability to differentiate into adipocytes and osteoblasts. CB depleted mMSC had high purity and expressed key mMSC markers (>85% Sca-1, CD29, CD90) with no mature hematopoietic contaminating cells (<5% CD45, CD11b) when subcultured to passage 5 (P5). Nondepleted mMSC cultures, however, were less pure and heterogenous with <72% Sca-1+, CD29+, and CD90+ cells at early passages (P1 or P2), along with high percentages of contaminating CD11b+ (35.6%) and CD45+ (39.2%) cells that persisted in culture long term. Depleted and nondepleted mMSC nevertheless exhibited similar potency to suppress total (CD3+), CD4+ and CD8+ T cell proliferation, in a dendritic cell allostimulatory one-way mixed lymphocyte reaction. CB depleted mMSC, pretreated with proinflammatory cytokines IFN-γ, TNF-α, and IL-17A, showed superior suppression of CD8+ T cell, but not CD4+ T cell proliferation, relative to untreated-mMSC. In conclusion, CB depleted mMSC established under hypoxic conditions and treated with selective cytokines represent a novel source of potent immunosuppressive MSC. As these cells have enhanced immune modulatory function, they may represent a superior product for use in clinical allotransplantation.

Entities:  

Keywords:  T cells; compact bone mesenchymal stem cells; hypoxia; immunodepletion; immunosuppression; proinflammatory cytokines

Mesh:

Substances:

Year:  2017        PMID: 27998209     DOI: 10.1089/scd.2016.0180

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  4 in total

Review 1.  Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential.

Authors:  Na Song; Martijn Scholtemeijer; Khalid Shah
Journal:  Trends Pharmacol Sci       Date:  2020-07-22       Impact factor: 14.819

2.  The Pro-reparative Engine: Stem Cells Aid Healing by Dampening Inflammation.

Authors:  Andrew Bradshaw; Kyle Sylakowski; Alan Wells
Journal:  Curr Pathobiol Rep       Date:  2018-03-20

3.  Let-7f miRNA regulates SDF-1α- and hypoxia-promoted migration of mesenchymal stem cells and attenuates mammary tumor growth upon exosomal release.

Authors:  Virginia Egea; Kai Kessenbrock; Devon Lawson; Alexander Bartelt; Christian Weber; Christian Ries
Journal:  Cell Death Dis       Date:  2021-05-20       Impact factor: 8.469

Review 4.  Role of Lysosomal Acidification Dysfunction in Mesenchymal Stem Cell Senescence.

Authors:  Weijun Zhang; Jinwu Bai; Kai Hang; Jianxiang Xu; Chengwei Zhou; Lijun Li; Zhongxiang Wang; Yibo Wang; Kanbin Wang; Deting Xue
Journal:  Front Cell Dev Biol       Date:  2022-02-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.